The future looks bright for HCV patients who have failed to respond to current treatments
Friday, April 1, 2011 - 11:04
in Health & Medicine
Berlin, Germany, Friday 1st April 2011: Highly anticipated data from a number of clinical trials presented for the first time at the International Liver CongressTM confirmed that a range of new proteases inhibitors will help treat patients who have previously failed therapy for the treatment of chronic hepatitis C.1,2,3,4,5